PHARMA-SKAN ApS: Financial statements 2015
CVR: 16275247
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
PHARMA-SKAN ApS (CVR 16275247) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 14,994,922 and a net result of DKK 11,200,711 compared with DKK 8,316,065 the year before. That is an increase of 30.8% compared with the year before. Equity in the 2015 report amounted to DKK 15,319,933. The solvency ratio was 33.9%. The company had 10 employees in the financial year.
- Gross Profit
- DKK 14,994,922
- Profit/Loss
- DKK 11,200,711
- Equity
- DKK 15,319,933
- Total Assets
- DKK 45,149,225
- Employees
- 10
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 15 mio. | 11.2 mio. | 15.3 mio. | 10 |
| 2014 | - | 11.5 mio. | 8.3 mio. | 14.1 mio. | 8 |
| 2013 | - | 11.4 mio. | 8.2 mio. | 15.8 mio. | 9 |
| 2012 | - | 11.6 mio. | 8.4 mio. | 17.6 mio. | 10 |
Official annual report
How creditworthy is PHARMA-SKAN ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
PHARMA-SKAN ApS has published its annual report for 2014. Gross profit came to DKK 11,464,201, and the net result was DKK 8,316,065.
About PHARMA-SKAN ApS
PHARMA-SKAN ApS is a Danish company of the type Anpartsselskab based in Skanderborg, founded in 1992. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named ApS KBUS 38 NR. 2587. The management consists of Line Wulff and Ib Gunnar Christensen. The board consists of Jan Dam (chair), Kent Ernst Hansen, Lars Enghave Minor and Line Wulff. The company is owned by BESULA ApS. The company has 19 employees (2026). In 2025, the company reported a gross profit of DKK 12,339,941 and a net result of DKK 7,875,190 compared with DKK 11,288,304 the year before. Equity in the 2025 report amounted to DKK 8,543,005.